Ionis Pharma (IONS) Misses Q1 EPS by 2c
Ionis Pharma (NASDAQ: IONS) reported Q1 EPS of $0.03, $0.02 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $110.3 million versus the consensus estimate of $116.45 million.
For earnings history and earnings-related data on Ionis Pharma (IONS) click here.